Abstract
The antigonococcal activity of the quinolone derivative flumequine was evaluated. Of 246 strains examined, 240 (97.5%) strains showed minimum inhibitory concentrations (MICs) of flumequine of less than or equal to 0.4 microgram/ml, including three beta-lactamase-producing strains. The six remaining strains showed MICs from 3.2 to 9.6 micrograms/ml. By disc diffusion tests using 3-micrograms discs of flumequine the zones of growth inhibition correlated well with the MICs of flumequine. The effect of treatment with flumequine was compared in 239 patients with uncomplicated gonorrhoea. A single dose regimen of 1200 mg flumequine orally, a two-dose regimen of 1200 and 800 mg, and a three-dose regimen of 1200, 800, and 800 mg (six hours apart) were given. With a single dose of flumequine the failure rate was 26%. The two-dose and three-dose regimens were equally effective with an overall cure rate of 95.4%. In patients harbouring beta-lactamase-producing gonococci the infection was cured. The failures (10 men) included all of the six patients infected with flumequine-resistant gonococci. Side effects were noted by 14.6% of the patients and were mostly described as dizziness.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dobson R. A., O'Connor J. R., Poulin S. A., Kundsin R. B., Smith T. F., Came P. E. In vitro antimicrobial activity of rosoxacin against Neisseria gonorrhoeae, Chlamydia trachomatis, and Ureaplasma urealyticum. Antimicrob Agents Chemother. 1980 Nov;18(5):738–740. doi: 10.1128/aac.18.5.738. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gordts B., Vanhoof R., Hubrechts J. M., Dierickx R., Coignau H., Butzler J. P. In-vitro activity of 21 antimicrobial agents against Neisseria gonorrhoeae in Brussels. Br J Vener Dis. 1982 Feb;58(1):23–28. doi: 10.1136/sti.58.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seth A. D. Sensitivity of gonococci to rosoxacin compared with that of penicillin, cefuroxime and tetracycline. J Antimicrob Chemother. 1981 Apr;7(4):331–334. doi: 10.1093/jac/7.4.331. [DOI] [PubMed] [Google Scholar]
- Svarva P. L., Maeland J. A. Comparison of two selective media in the cultural diagnosis of Gonorrhoea. Acta Pathol Microbiol Scand B. 1979 Dec;87(6):391–392. doi: 10.1111/j.1699-0463.1979.tb02456.x. [DOI] [PubMed] [Google Scholar]
- Warren C. A., Shannon K. P., Phillips I. In-vitro antigonococcal activity of rosoxacin (WIN 35213). Br J Vener Dis. 1981 Feb;57(1):33–35. doi: 10.1136/sti.57.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]